APO Research
Talk to an analyst

APO RESEARCH · REPORT

Proto Oncogene Tyrosine Protein Kinase Src

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Proto Oncogene Tyrosine Protein Kinase Src Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026183 pages

Choose your research edition.

Industry ResearchProto Oncogene Tyrosine Protein Kinase Src Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Proto Oncogene Tyrosine Protein Kinase Src Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Proto Oncogene Tyrosine Protein Kinase Src Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Proto Oncogene Tyrosine Protein Kinase Src Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Proto Oncogene Tyrosine Protein Kinase Src Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Proto Oncogene Tyrosine Protein Kinase Src market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Proto Oncogene Tyrosine Protein Kinase Src is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Proto Oncogene Tyrosine Protein Kinase Src is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Proto Oncogene Tyrosine Protein Kinase Src is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Proto Oncogene Tyrosine Protein Kinase Src is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Proto Oncogene Tyrosine Protein Kinase Src include Avalyn Pharma Inc, KeifeRx LLC, Lead Discovery Center GmbH, TopiVert Ltd, Turning Point Therapeutics Inc, AstraZeneca Plc, AbbVie Inc, Boehringer Ingelheim International GmbH and Taiwan Liposome Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Proto Oncogene Tyrosine Protein Kinase Src market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Proto Oncogene Tyrosine Protein Kinase Src and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Proto Oncogene Tyrosine Protein Kinase Src sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Proto Oncogene Tyrosine Protein Kinase Src market size, projected growth trends, production technologies, key applications, and end-use industries.

Proto Oncogene Tyrosine Protein Kinase Src Segment by Company

Avalyn Pharma Inc

KeifeRx LLC

Lead Discovery Center GmbH

TopiVert Ltd

Turning Point Therapeutics Inc

AstraZeneca Plc

AbbVie Inc

Boehringer Ingelheim International GmbH

Taiwan Liposome Co Ltd

Proto Oncogene Tyrosine Protein Kinase Src Segment by Type

Proto Oncogene c Src

SRC

Pp60c src

EC 2.7.10.2

Proto Oncogene Tyrosine Protein Kinase Src Segment by Application

Infectious Disease

Respiratory

Musculoskeletal Disorders

Gastrointestinal

Ophthalmology

Genetic Disorders

Central Nervous System

Oncology

Proto Oncogene Tyrosine Protein Kinase Src Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proto Oncogene Tyrosine Protein Kinase Src market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Proto Oncogene Tyrosine Protein Kinase Src and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proto Oncogene Tyrosine Protein Kinase Src.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Proto Oncogene Tyrosine Protein Kinase Src market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Proto Oncogene Tyrosine Protein Kinase Src manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Proto Oncogene Tyrosine Protein Kinase Src in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Proto Oncogene Tyrosine Protein Kinase Src in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Proto Oncogene Tyrosine Protein Kinase Src Industry Trends Table 2. Proto Oncogene Tyrosine Protein Kinase Src Industry Drivers Table 3. Proto Oncogene Tyrosine Protein Kinase Src Industry Opportunities and Challenges Table 4. Proto Oncogene Tyrosine Protein Kinase Src Industry Restraints Table 5. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Manufacturers Table 9. Global Proto Oncogene Tyrosine Protein Kinase Src Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Proto Oncogene Tyrosine Protein Kinase Src Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Proto Oncogene Tyrosine Protein Kinase Src Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Proto Oncogene Tyrosine Protein Kinase Src Manufacturers, Product Type & Application Table 13. Global Proto Oncogene Tyrosine Protein Kinase Src Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Proto Oncogene Tyrosine Protein Kinase Src by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Proto Oncogene c Src Table 17. Major Manufacturers of SRC Table 18. Major Manufacturers of Pp60c src Table 19. Major Manufacturers of EC 2.7.10.2 Table 20. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2026) & (K Units) Table 22. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2027-2032) & (K Units) Table 23. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2026) Table 24. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2027-2032) Table 25. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021-2026) & (K Units) Table 27. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2027-2032) & (K Units) Table 28. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2026) Table 29. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Infectious Disease Table 31. Major Manufacturers of Respiratory Table 32. Major Manufacturers of Musculoskeletal Disorders Table 33. Major Manufacturers of Gastrointestinal Table 34. Major Manufacturers of Ophthalmology Table 35. Major Manufacturers of Genetic Disorders Table 36. Major Manufacturers of Central Nervous System Table 37. Major Manufacturers of Oncology Table 38. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2026) & (K Units) Table 40. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2027-2032) & (K Units) Table 41. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2026) Table 42. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2027-2032) Table 43. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021-2026) & (K Units) Table 45. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2027-2032) & (K Units) Table 46. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2026) Table 47. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2027-2032) Table 48. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2021-2026) & (K Units) Table 50. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2021-2026) Table 51. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 55. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 56. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 58. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2027-2032) & (K Units) Table 65. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2021-2026) Table 69. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2027-2032) Table 70. Avalyn Pharma Inc Company Information Table 71. Avalyn Pharma Inc Business Overview Table 72. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 74. Avalyn Pharma Inc Recent Development Table 75. KeifeRx LLC Company Information Table 76. KeifeRx LLC Business Overview Table 77. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 79. KeifeRx LLC Recent Development Table 80. Lead Discovery Center GmbH Company Information Table 81. Lead Discovery Center GmbH Business Overview Table 82. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 84. Lead Discovery Center GmbH Recent Development Table 85. TopiVert Ltd Company Information Table 86. TopiVert Ltd Business Overview Table 87. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 89. TopiVert Ltd Recent Development Table 90. Turning Point Therapeutics Inc Company Information Table 91. Turning Point Therapeutics Inc Business Overview Table 92. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 94. Turning Point Therapeutics Inc Recent Development Table 95. AstraZeneca Plc Company Information Table 96. AstraZeneca Plc Business Overview Table 97. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 99. AstraZeneca Plc Recent Development Table 100. AbbVie Inc Company Information Table 101. AbbVie Inc Business Overview Table 102. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 104. AbbVie Inc Recent Development Table 105. Boehringer Ingelheim International GmbH Company Information Table 106. Boehringer Ingelheim International GmbH Business Overview Table 107. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 109. Boehringer Ingelheim International GmbH Recent Development Table 110. Taiwan Liposome Co Ltd Company Information Table 111. Taiwan Liposome Co Ltd Business Overview Table 112. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio Table 114. Taiwan Liposome Co Ltd Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Proto Oncogene Tyrosine Protein Kinase Src Distributors List Table 118. Proto Oncogene Tyrosine Protein Kinase Src Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Proto Oncogene Tyrosine Protein Kinase Src Product Image Figure 2. Global Proto Oncogene Tyrosine Protein Kinase Src Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Proto Oncogene Tyrosine Protein Kinase Src Market Size (2021-2032) & (US$ Million) Figure 4. Global Proto Oncogene Tyrosine Protein Kinase Src Sales (2021-2032) & (K Units) Figure 5. Global Proto Oncogene Tyrosine Protein Kinase Src Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Proto Oncogene Tyrosine Protein Kinase Src Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Proto Oncogene c Src Image Figure 9. SRC Image Figure 10. Pp60c src Image Figure 11. EC 2.7.10.2 Image Figure 12. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2032) Figure 15. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2032) Figure 18. Infectious Disease Image Figure 19. Respiratory Image Figure 20. Musculoskeletal Disorders Image Figure 21. Gastrointestinal Image Figure 22. Ophthalmology Image Figure 23. Genetic Disorders Image Figure 24. Central Nervous System Image Figure 25. Oncology Image Figure 26. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2032) Figure 29. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2032) Figure 32. North America Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 34. U.S. Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 39. Germany Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 46. China Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2021-2032) Figure 54. Brazil Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Proto Oncogene Tyrosine Protein Kinase Src Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032) & (US$ Million) Figure 65. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032) & (US$ Million) Figure 67. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Proto Oncogene Tyrosine Protein Kinase Src Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Proto Oncogene Tyrosine Protein Kinase Src Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Proto Oncogene c Src
  • SRC
  • Pp60c src
  • EC 2.7.10.2
Applications
  • Infectious Disease
  • Respiratory
  • Musculoskeletal Disorders
  • Gastrointestinal
  • Ophthalmology
  • Genetic Disorders
  • Central Nervous System
  • Oncology
Companies covered
  • Avalyn Pharma Inc
  • KeifeRx LLC
  • Lead Discovery Center GmbH
  • TopiVert Ltd
  • Turning Point Therapeutics Inc
  • AstraZeneca Plc
  • AbbVie Inc
  • Boehringer Ingelheim International GmbH
  • Taiwan Liposome Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Proto Oncogene Tyrosine Protein Kinase Src Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Proto Oncogene Tyrosine Protein Kinase Src Market Dynamics
  1. 2.1 Proto Oncogene Tyrosine Protein Kinase Src Industry Trends
  2. 2.2 Proto Oncogene Tyrosine Protein Kinase Src Industry Drivers
  3. 2.3 Proto Oncogene Tyrosine Protein Kinase Src Industry Opportunities and Challenges
  4. 2.4 Proto Oncogene Tyrosine Protein Kinase Src Industry Restraints
3 Proto Oncogene Tyrosine Protein Kinase Src Market by Manufacturers
  1. 3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Manufacturers (2021-2026)
  3. 3.3 Global Proto Oncogene Tyrosine Protein Kinase Src Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Proto Oncogene Tyrosine Protein Kinase Src Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Proto Oncogene Tyrosine Protein Kinase Src Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Proto Oncogene Tyrosine Protein Kinase Src Manufacturers, Product Type & Application
  7. 3.7 Global Proto Oncogene Tyrosine Protein Kinase Src Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Proto Oncogene Tyrosine Protein Kinase Src Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Proto Oncogene Tyrosine Protein Kinase Src Tier 1, Tier 2, and Tier 3
4 Proto Oncogene Tyrosine Protein Kinase Src Market by Type
  1. 4.1 Proto Oncogene Tyrosine Protein Kinase Src Type Introduction
  2. 4.1.1 Proto Oncogene c Src
  3. 4.1.2 SRC
  4. 4.1.3 Pp60c src
  5. 4.1.4 EC 2.7.10.2
  6. 4.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type
  7. 4.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2021-2032)
  9. 4.2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2021-2032)
  10. 4.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type
  11. 4.3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2021-2032)
  13. 4.3.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2021-2032)
5 Proto Oncogene Tyrosine Protein Kinase Src Market by Application
  1. 5.1 Proto Oncogene Tyrosine Protein Kinase Src Application Introduction
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Respiratory
  4. 5.1.3 Musculoskeletal Disorders
  5. 5.1.4 Gastrointestinal
  6. 5.1.5 Ophthalmology
  7. 5.1.6 Genetic Disorders
  8. 5.1.7 Central Nervous System
  9. 5.1.8 Oncology
  10. 5.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application
  11. 5.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2021-2032)
  13. 5.2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2021-2032)
  14. 5.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application
  15. 5.3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2021-2032)
  17. 5.3.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2021-2032)
6 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region
  1. 6.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2021-2032)
  3. 6.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2021-2026)
  4. 6.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region
  1. 7.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region
  2. 7.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2021-2026)
  4. 7.1.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2027-2032)
  5. 7.1.4 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032)
  8. 7.2.2 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032)
  11. 7.3.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Avalyn Pharma Inc
  2. 8.1.1 Avalyn Pharma Inc Company Information
  3. 8.1.2 Avalyn Pharma Inc Business Overview
  4. 8.1.3 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  6. 8.1.5 Avalyn Pharma Inc Recent Developments
  7. 8.2 KeifeRx LLC
  8. 8.2.1 KeifeRx LLC Company Information
  9. 8.2.2 KeifeRx LLC Business Overview
  10. 8.2.3 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  12. 8.2.5 KeifeRx LLC Recent Developments
  13. 8.3 Lead Discovery Center GmbH
  14. 8.3.1 Lead Discovery Center GmbH Company Information
  15. 8.3.2 Lead Discovery Center GmbH Business Overview
  16. 8.3.3 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  18. 8.3.5 Lead Discovery Center GmbH Recent Developments
  19. 8.4 TopiVert Ltd
  20. 8.4.1 TopiVert Ltd Company Information
  21. 8.4.2 TopiVert Ltd Business Overview
  22. 8.4.3 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  24. 8.4.5 TopiVert Ltd Recent Developments
  25. 8.5 Turning Point Therapeutics Inc
  26. 8.5.1 Turning Point Therapeutics Inc Company Information
  27. 8.5.2 Turning Point Therapeutics Inc Business Overview
  28. 8.5.3 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  30. 8.5.5 Turning Point Therapeutics Inc Recent Developments
  31. 8.6 AstraZeneca Plc
  32. 8.6.1 AstraZeneca Plc Company Information
  33. 8.6.2 AstraZeneca Plc Business Overview
  34. 8.6.3 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  36. 8.6.5 AstraZeneca Plc Recent Developments
  37. 8.7 AbbVie Inc
  38. 8.7.1 AbbVie Inc Company Information
  39. 8.7.2 AbbVie Inc Business Overview
  40. 8.7.3 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  42. 8.7.5 AbbVie Inc Recent Developments
  43. 8.8 Boehringer Ingelheim International GmbH
  44. 8.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 8.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 8.8.3 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  48. 8.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 8.9 Taiwan Liposome Co Ltd
  50. 8.9.1 Taiwan Liposome Co Ltd Company Information
  51. 8.9.2 Taiwan Liposome Co Ltd Business Overview
  52. 8.9.3 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
  54. 8.9.5 Taiwan Liposome Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Proto Oncogene Tyrosine Protein Kinase Src Value Chain Analysis
  2. 9.1.1 Proto Oncogene Tyrosine Protein Kinase Src Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Proto Oncogene Tyrosine Protein Kinase Src Production Mode & Process
  6. 9.2 Proto Oncogene Tyrosine Protein Kinase Src Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Proto Oncogene Tyrosine Protein Kinase Src Distributors
  9. 9.2.3 Proto Oncogene Tyrosine Protein Kinase Src Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst